UK first to source coronavirus vaccines from biotech firms backed by Bill Gates
Published
The UK government revealed its stockpile of coronavirus (COVID-19) treatments on Monday, having recently secured 90 million doses of potential vaccines. Britain’s fresh agreement with Germany’s BioNTech and the Bill Gates-backed Pfizer netted 30 million doses of their joint mRNA vaccine, a first for any world government. The two companies joined forces in March to fast-track development. [Read: A look at the $17 billion stock portfolio of the Bill and Melinda Gates Foundation] French biotech company Valneva will provide 60 million doses of their “inactivated whole virus” vaccine. The UK has the option to purchase a further 40 million doses if…
This story continues at The Next Web